[1]
S. Çokgezer, M. Senkal, A. Safaraliyeva, H. U. Bozbey, and D. Taştekin, “Hematologic Toxicity During First-Line Platinum-Based Chemotherapy in BRCA-Mutated Ovarian Cancer: Predictors and Survival Impact”, Cerrahpaşa Medical Journal, vol. 50, pp. 1–8, Jul. 2026.